The Law Offices of Frank R. Cruz announces an investigation of Beta Bionics, Inc. ("Beta Bionics" or the "Company") (NASDAQ: ...

The DJS Law Group announces that it is investigating claims on behalf of investors of Beta Bionics, Inc. ("Beta Bionics" or ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2025 ...

NEW YORK, NY - January 17, 2026 ( NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: ...

The projected fair value for Beta Bionics is US$20.69 based on 2 Stage Free Cash Flow to Equity. Current share price of US$17 ...

Ekso Bionics (EKSO) shares nearly doubled on Dec. 30 after Applied Digital (APLD) revealed plans of spinning off its cloud segment into a standalone business. The announcement sparked investor ...

Beta Bionics reported Q4 2025 sales growth, but analysts raised concerns about valuation and slower patient starts.

The downgrade comes after the Irvine-based medical device company reported preliminary fourth quarter results.

Shares of Beta Bionics fell after the maker of insulin-delivery systems shared preliminary data for new patient starts that were below expectations. The stock slipped 36%, to $20.5, on Friday. Over ...

IRVINE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its preliminary, ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. After getting caught in a blizzard while mountain climbing at age 17 ...

Generative Bionics, an Italian company developing Physical AI powered humanoid robots, unveiled its first concept at CES 2026 ...